Business Context and Reporting Period
This Form 8-K reports on the 2019 Annual Meeting of Stockholders for Rocket Pharmaceuticals, Inc., held on June 17, 2019. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol RCKT. The filing details the voting results for the election of directors and the ratification of the independent registered accounting firm.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is a current report focused solely on corporate governance events.
Material Changes
No material financial changes are reported in this filing. The primary event is the completion of the Annual Meeting where stockholders voted on two proposals. Approximately 87.51% of eligible shares were present in person or by proxy.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of risks and contingencies. It strictly documents the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Director Election: All seven nominees were elected to the Board of Directors. Naveen Yalamanchi received the highest number of votes withheld (8,464,557) compared to other nominees.
- Accounting Firm Ratification: Stockholders ratified the appointment of EisnerAmper LLP as the independent registered accounting firm for the fiscal year ending December 31, 2019.
- Voting Participation: 44,008,496 shares were present at the meeting, representing 87.51% of total outstanding shares eligible to be voted.
- Broker Non-Votes: There were 10,102,851 broker non-votes recorded for the election of directors, which did not affect the outcome as the proposals required a plurality of votes cast.